|
Nov 13
|
Heron Therapeutics Inc (HRTX) Q3 2024 Earnings Call Highlights: Strategic Initiatives Drive ...
|
|
Nov 12
|
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Nov 12
|
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
|
|
Nov 12
|
Heron Therapeutics: Q3 Earnings Snapshot
|
|
Nov 12
|
Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
|
|
Nov 7
|
Unveiling Heron Therapeutics (HRTX) Q3 Outlook: Wall Street Estimates for Key Metrics
|
|
Nov 5
|
Positive Signs As Multiple Insiders Buy Heron Therapeutics Stock
|
|
Nov 4
|
Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors
|
|
Nov 4
|
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock?
|
|
Oct 29
|
Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024
|
|
Apr 11
|
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
|
|
Mar 28
|
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 12
|
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
|
|
Mar 7
|
Oncternal Therapeutics (ONCT) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 7
|
Curious about Heron Therapeutics (HRTX) Q4 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Jan 15
|
Heron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy?
|